New powdered plasma shows promise for stopping bleeding
NCT ID NCT05629338
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study tested the safety of a new spray-dried plasma called FrontlineODP in 24 healthy volunteers. Participants received increasing doses (1, 2, or 4 units) and were compared to those receiving standard frozen plasma (PF24). The goal was to see if the product causes side effects and how it affects blood clotting. This research helps develop a portable plasma product for treating severe bleeding in emergencies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hoxworth Blood Center
Cincinnati, Ohio, 45267-0055, United States
-
Spaulding Clinical Research LLC
West Bend, Wisconsin, 53095, United States
-
Versiti Blood Center of Wisconsin
Milwaukee, Wisconsin, 53233, United States
Conditions
Explore the condition pages connected to this study.